Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹1,231 Cr
up ₹2.7 Cr vs Dec 2022
- Stocks held
- 24
- unchanged
- Top 10 weight
- 64.9%
- of the portfolio in its ten largest
- Cash & debt
- 2.6%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 12
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In January 2023 it disclosed 24 stocks worth ₹1,231 Cr, up ₹2.7 Cr from Dec 2022. Its largest positions were Sun Pharmaceutical Industries Limited (17.8%), Cipla Limited (8.6%), Apollo Hospitals Enterprise Limited (6.4%); the ten largest together made up 64.9% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 67.6% of its equity. Cash and debt stood at 2.6%. Compared with Dec 2022 the fund entered 0 new stocks and exited 0.
Against 229 other Sectoral / Thematic funds
Concentration
89%
Top-10 weight is higher than 89% of peers
Breadth
7%
Holds more stocks than 7% of peers
Cash
35%
Holds more cash than 35% of peers
What these mean: concentration · cash
Holdings in January 2023
Download CSVEvery line the fund disclosed, with the change against Dec 2022. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Sun Pharmaceutical Industries Limited | 17.76% | up 1.51 pts | ₹219 Cr | up ₹19.1 Cr | Added |
| Cipla Limited | 8.57% | down 0.51 pts | ₹105 Cr | down ₹6 Cr | Trimmed |
| Apollo Hospitals Enterprise Limited | 6.44% | down 0.35 pts | ₹79.2 Cr | down ₹4.1 Cr | Trimmed |
| Lupin Limited | 5.86% | up 0.51 pts | ₹72.1 Cr | up ₹6.4 Cr | Added |
| IPCA Laboratories Limited | 5.45% | up 0.03 pts | ₹67.1 Cr | up ₹53 L | Added |
| Procter & Gamble Health Limited | 5.28% | up 0.17 pts | ₹65 Cr | up ₹2.2 Cr | Added |
| Alkem Laboratories Limited | 4.35% | up <0.01 pts | ₹53.6 Cr | up ₹12 L | Held |
| Dr. Reddy's Laboratories Limited | 3.93% | up 0.07 pts | ₹48.4 Cr | up ₹97 L | Added |
| Alembic Pharmaceuticals Limited | 3.84% | up 0.84 pts | ₹47.3 Cr | up ₹10.5 Cr | Added |
| Vijaya Diagnostic Centre Limited | 3.41% | down 0.21 pts | ₹42 Cr | down ₹2.5 Cr | Trimmed |
| Suven Pharmaceuticals Limited | 3.41% | up 1.00 pts | ₹41.9 Cr | up ₹12.4 Cr | Added |
| Zydus Lifesciences Limited | 3.37% | up 1.31 pts | ₹41.5 Cr | up ₹16.2 Cr | Added |
| Globus Medical Inc | 3.32% | down 0.03 pts | ₹40.9 Cr | down ₹32 L | Trimmed |
| Indoco Remedies Limited | 3.25% | down 0.47 pts | ₹40 Cr | down ₹5.7 Cr | Trimmed |
| Intuitive Surgical Inc | 3.02% | down 0.34 pts | ₹37.2 Cr | down ₹4.1 Cr | Trimmed |
| Cash, TREPS & receivables | 2.57% | down 1.63 pts | ₹31.7 Cr | down ₹20 Cr | Trimmed |
| Aarti Drugs Limited | 2.33% | down 0.35 pts | ₹28.7 Cr | down ₹4.2 Cr | Trimmed |
| Abbott Laboratories | 2.30% | down 0.04 pts | ₹28.3 Cr | down ₹45 L | Trimmed |
| ICICI Lombard General Insurance Company Limited | 2.22% | down 0.22 pts | ₹27.3 Cr | down ₹2.6 Cr | Trimmed |
| Global X Funds - Global X Genomics & Biotechnology ETF Fund units | 1.78% | up 0.08 pts | ₹21.9 Cr | up ₹1 Cr | Added |
| Syngene International Limited | 1.71% | down 0.07 pts | ₹21.1 Cr | down ₹87 L | Trimmed |
| Kovai Medical Center and Hospital Limited | 1.64% | up 0.06 pts | ₹20.2 Cr | up ₹80 L | Added |
| Max Healthcare Institute Limited | 1.53% | down 1.36 pts | ₹18.9 Cr | down ₹16.7 Cr | Trimmed |
| Illumina Inc | 1.18% | up 0.03 pts | ₹14.5 Cr | up ₹41 L | Added |
| MedPlus Health Services Limited | 0.99% | up 0.03 pts | ₹12.2 Cr | up ₹44 L | Added |
| Pfizer Limited | 0.48% | down 0.07 pts | ₹5.9 Cr | down ₹86 L | Trimmed |
What changed, Dec 2022 to Jan 2023
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Sun Pharmaceutical Industries Limitedup ₹19.1 Cr (+1.51% pts)
- Zydus Lifesciences Limitedup ₹16.2 Cr (+1.31% pts)
- Suven Pharmaceuticals Limitedup ₹12.4 Cr (+1.00% pts)
- Alembic Pharmaceuticals Limitedup ₹10.5 Cr (+0.84% pts)
- Lupin Limited ₹6.4 Cr (+0.51% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Dec 2022, the weight rose most in Pharmaceuticals & Biotechnology (+3.7 pts), and fell most in Healthcare Services (−2.3 pts) and Pharmaceuticals (−0.6 pts).
- Pharmaceuticals & Biotechnology63.9% → 67.6%+3.7 pts
- Healthcare Services18.9% → 16.6%−2.3 pts
- Pharmaceuticals6.4% → 5.8%−0.6 pts
- Healthcare Equipment & Supplies7.1% → 6.6%−0.5 pts
- Insurance2.6% → 2.3%−0.3 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Jan 2020 | Jan 2022 | Jul 2022 | Oct 2022 | Dec 2022 | Jan 2023 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 65.6% | 54.0% | 57.0% | 61.4% | 63.9% | 67.6% |
| Healthcare Services | 21.6% | 29.3% | 26.0% | 23.3% | 18.9% | 16.6% |
| Healthcare Equipment & Supplies | — | 5.5% | 5.6% | 6.4% | 7.1% | 6.6% |
| Pharmaceuticals | 11.4% | 7.0% | 7.7% | 5.6% | 6.4% | 5.8% |
| Insurance | 1.4% | 2.6% | 2.5% | 2.4% | 2.6% | 2.3% |
| Retailing | — | 1.6% | 1.2% | 1.0% | 1.0% | 1.0% |
Allocation in Jan 2023change vs Dec 2022
- Pharmaceuticals & Biotechnology (12)67.6%▲ 3.7 pts
- Healthcare Services (6)16.6%▼ 2.3 pts
- Healthcare Equipment & Supplies (2)6.6%▼ 0.5 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Jan 2023
2.6%
▼ 1.6 pts vs Dec 2022
- Cash alone
- 2.6%
- cash and net receivables
- A year earlier
- −0.1%
- Jan 2022 · now ▲ 2.7 pts
- Last 12 months
- −<0.1% – 4.2%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.